Iloprost: all 61 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial HypertensionRecruitingNCT07713914Phase 4
- Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell DiseaseNot yet recruitingNCT07498309Phase 3
- Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory FailureRecruitingNCT06319274Phase 2
- Outpatient Vasodilator Assessment Using Iloprost in Pulmonary HypertensionTerminatedNCT03044314Phase 4Results posted
- Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric OxideTerminatedNCT02170519Phase 4Results posted
- Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT01437878Phase 2Results posted
- Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart DiseaseTerminatedNCT01319045Not applicableResults posted
- Iloprost Power Disc-15 in Pulmonary Arterial HypertensionTerminatedNCT00723554Phase 3Results posted
- Iloprost Power 15 in Pulmonary Arterial HypertensionCompletedNCT00709956Phase 3Results posted
- Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial HypertensionCompletedNCT00709098Phase 3Results posted
- The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 SettingTerminatedNCT00467896Phase 2Results posted
- The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial HypertensionTerminatedNCT00302211Phase 3Results posted
- Iloprost in Preventing Lung Cancer in Patients at High Risk for This DiseaseCompletedNCT00084409Phase 2Results posted
- Oral Iloprost for the Prevention of Lung Cancer In Former SmokersWithdrawnNCT05411107Phase 2
- Effect of Intraoperative Iloprost Inhalant on Hemodynamic Stability in Patients Undergoing Off-pump Coronary Artery Bypass Graft SurgeryStatus unknownNCT04598191Not applicable
- A Clinical Trial Investigating Iloprost as Medication to Improve Bone Healing in Patients With Proximal Humeral FractureStatus unknownNCT04543682Phase 1/2
- Inhaled Iloprost for Suspected COVID-19 Respiratory FailureCompletedNCT04445246Phase 2
- Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory FailureCompletedNCT04420741Phase 2
- Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ FailureCompletedNCT04123444Phase 2/3
- The Effect of Iloprost on Oxygenation During One-lung Ventilation for Lung SurgeryCompletedNCT03936140Not applicable
- Infusion of Prostacyclin vs Placebo for 72-hours in Trauma Patients With Haemorrhagic Shock Suffering From Organ FailureCompletedNCT03903939Phase 2
- ILOPROST in Septic Shock With Persistent Microperfusion Defects (I-MICRO)CompletedNCT03788837Phase 3
- Inhaled Iloprost and Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection FractionStatus unknownNCT03620526Phase 4
- The Effect of Iloprost on Capillary Recruitment and Insulin Sensitivity in Type 2 DiabetesCompletedNCT03380325Not applicable
- Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial HypertensionCompletedNCT03365479Not applicable
- Iloprost in Acute Respiratory Distress SyndromeCompletedNCT03111212Phase 3
- Effect of Iloprost on Pulmonary Oxygenation in Patients With Low Diffusing Capacity During One-lung VentilationCompletedNCT02784899Not applicable
- Endothelial Dysfunction in Resuscitated Cardiac ArrestCompletedNCT02685618Phase 2
- Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung VentilationCompletedNCT02490657Not applicable
- Iloprost for Bridging to Heart Transplantation in PHWithdrawnNCT02482402Phase 2
- Use of Ventavis in Patients With Postembolic Residual Pulmonary HypertensionStatus unknownNCT02238535Phase 2
- Iloprost in Preventing Lung Cancer in Former SmokersCompletedNCT02237183Phase 1
- Co-administration of Iloprost and Eptifibatide in Septic Shock PatientsCompletedNCT02204852Phase 2
- Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD PatientsCompletedNCT01941225Phase 2
- The Arterial Measurement of the Blood Flow Volume After Iloprost StimulationStatus unknownNCT01774058Phase 2
- Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)CompletedNCT01718288Phase 4
- Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension PatientsStatus unknownNCT01712997Phase 3
- Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)CompletedNCT01598441Phase 3
- Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe SepsisTerminatedNCT01532544Phase 2
- Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation StudyCompletedNCT01469169Phase 3
- Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart DiseaseCompletedNCT01320878Phase 2
- Iloprost Effects on Gas Exchange and Pulmonary MechanicsCompletedNCT01274481Phase 1
- Inhaled Iloprost in Mild AsthmaCompletedNCT01209533Early Phase 1
- Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI)CompletedNCT01179776Phase 1/2
- Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT01116063Phase 4
- Cutaneous Iontophoresis of Iloprost and Treprostinil in Healthy VolunteersCompletedNCT01082484Phase 1/2
- Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care PatientsWithdrawnNCT00981591Phase 1/2
- Iloprost in High Risk Cardiac Surgical PatientsCompletedNCT00927654Phase 3
- Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction at AltitudeWithdrawnNCT00724321Phase 1
- Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction and Exercise Capacity at High AltitudeStatus unknownNCT00708565Phase 1
- Effect of Different Iloprost Doses on Symptoms in Systemic SclerosisTerminatedNCT00622687Phase 2
- Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00561223Not applicable
- Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial HypertensionWithdrawnNCT00453414Phase 2
- Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary HypertensionCompletedNCT00414687Phase 2
- Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.TerminatedNCT00409526Phase 4
- Inhaled Iloprost for Sarcoidosis-associated Pulmonary HypertensionCompletedNCT00403650Phase 4
- Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or InterventionCompletedNCT00345501Phase 2/3
- Treatment of Elevated Arterial Pulmonary Pressure With Inhaled IloprostWithdrawnNCT00216931Not applicable
- Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary HypertensionCompletedNCT00185315Phase 3
- Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary FibrosisCompletedNCT00109681Phase 2
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT00004786Phase 3